And I thought this co. was just draining the bank account!
Now, with only 880K/yr of loss, they'll have to work harder.
But then, I also thought they were in Ma.
Caprius, Inc. Subsidiary, Opus Diagnostics Inc., Enters Into an
[CAPR-news]
Caprius, Inc. Subsidiary, Opus Diagnostics
Inc., Enters Into an Exclusive U.S. Distribution Agreement With
Polymedco, Inc.
FORT LEE, N.J.--(BUSINESS WIRE)--Sept. 26, 2000--Caprius, Inc.
(OTCBB: CAPR) announced today that its wholly owned subsidiary, Opus
Diagnostics Inc. (Opus), has entered into an exclusive distribution
agreement for the U.S. with Polymedco, Inc., effective October 1,
2000.
Polymedco, a New York based diagnostic company, will exclusively
market and sell the Opus line of quality recognized INNOFLUOR(R)
Therapeutic Drug Monitoring (TDM) assays throughout the United States.
This agreement allows Opus to utilize Polymedco's experienced
marketing department as well as its extensive sales force of 36 field
representatives and 6 regional sales managers, to fulfill the
diagnostic needs of the medical and research communities.
Polymedco will stock and distribute Opus' products from its
Cortlandt Manor, New York facility and will also offer a complete
range of complementary products. The Customer Service and Technical
Service Departments of Polymedco will provide Opus' customers with a
larger quality service and technical support group.
George Aaron, Caprius' President and CEO, stated, "We are
delighted to have concluded this agreement with Polymedco. Polymedco's
highly regarded sales force and quality customer service will inure to
the benefits of the Opus products in the U.S.A. We are confident that
the exposure our products will receive from Polymedco's marketing
force will help us to grow our company in a rapid and cost efficient
manner. Overseas we continue to expand our distribution channels and
sell our products in more than 20 countries."
Safe Harbor Statement:
The statements made in this press release that are not historical
fact are "forward-looking statements" which are based upon current
expectations that include a number of risks and uncertainties.
Additional factors that could potentially affect the Company's
financial results may be found on the Company's filings with the
Securities and Exchange Commission.
--30--aw/ny* csm
CONTACT: Caprius, Inc., Fort Lee
Beverly Tkaczenko, 201/592-8838
beverlyt@caprius.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
(c) 1998 Business Wire |
